Women have a higher mortality rate in ST-segment elevation acute myocardial infarction 

Original title: Is the difference in outcome between men and women treated by primary percutaneous coronary intervention age dependent?: Gender difference in STMI stratified on age Reference: Amber M Otten et, al.European Heart Journal Acute Cardiovascular Care January 31:1-8

Numerous publications have shown that women have worse outcomes than men in chronic ischemic heart disease but their evolution in the context of ST segment elevation acute myocardial infarction, (STEMI), has not been fully studied.

6,746 patients admitted with STEMI were analyzed between 1998 and 2008, dividing them into four groups: women under 65 years (n = 708), men younger than 65 years (n = 3,006), women older than 65 years (n = 1,045) and men older than 65 years (n = 1,985). 

Women had more time from the onset of symptoms to hospital admission as opposed to door-to-balloon time that was equal in both sexes. At initial angiography less obstructive disease was found, a higher TIMI 3 flow and a reduced release of CK in women younger than 65 years versus men in the same age group. In the larger group of over 65 years there was no difference between the sexes in multi-vessel disease and TIMI flow 3. The result after angioplasty in terms of TIMI and Blush was similar in both sexes. 

Overall mortality at thirty days and one year was greater in women. In the group under 65 years women had a higher mortality rate at both thirty days and one year. For those over 65 years the mortality rate was higher only after thirty days.

Conclusion: 

The difference in mortality between men and women admitted with an acute ST segment elevation was age dependent. Young women had less frequent coronary obstruction and TIMI 3 flow before angioplasty, suggesting a lower risk, yet their prognosis was worse compared with men of the same age.

Comment: 

The delay in consulting a hospital from the onset of symptoms may explain the impact on mortality in women. 

Courtesy Dr Carlos Fava.
Interventional Cardiologist.
Favaloro Foundation. 

Dr. Carlos Fava para SOLACI.ORG

More articles by this author

CRT 2026 | CUT-DRESS Trial: Lesion Preparation with Cutting Balloon

In-stent restenosis (ISR) continues to represent a relevant clinical challenge in contemporary coronary angioplasty practice. Despite advances in drug-eluting stents, neointimal hyperplasia and suboptimal...

CRT 2026 | Clopidogrel vs Aspirin as Long-Term Monotherapy After Coronary Angioplasty

The use of aspirin as chronic antiplatelet therapy after percutaneous coronary intervention (PCI) has historically been the standard recommended by international guidelines. However, recent...

Bioresorbable devices vs DES in patients at high risk of restenosis. Seven-year follow-up of the COMPARE-ABSORB trial

Studies with second-generation drug-eluting stents (DES) have shown that the rate of target lesion failure (TLF) increases linearly up to 5–10 years of follow-up,...

Sheathless Femoral Impella: A New Strategy to Reduce Vascular Complications in High-Risk PCI?

Patients with complex coronary artery disease or cardiogenic shock undergoing percutaneous coronary intervention (PCI) may benefit from the hemodynamic support provided by percutaneous ventricular...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

CRT 2026 | TAVI-CLOSE Trial: Dual Suture vs Suture + Plug for Vascular Closure After Transfemoral TAVI

The transfemoral approach is the predominant strategy for transcatheter aortic valve implantation (TAVI). Although vascular complications are currently less frequent, they remain relevant determinants...

CRT 2026 | NAVITOR IDE: Hemodynamic Outcomes and 5-Year Durability of an Intra-Annular Self-Expanding Transcatheter Aortic Valve

As TAVI expands into younger populations and patients with lower surgical risk, prosthesis durability has become a key aspect of long-term management. The NAVITOR...

CRT 2026 | CUT-DRESS Trial: Lesion Preparation with Cutting Balloon

In-stent restenosis (ISR) continues to represent a relevant clinical challenge in contemporary coronary angioplasty practice. Despite advances in drug-eluting stents, neointimal hyperplasia and suboptimal...